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Although the CRISPR/Cas system has enabled one-step generation of knockout mice, low success rates of cassette
knock-in limit its application range. Here we show that cloning-free, direct nuclear delivery of Cas9 protein complex
with chemically synthesized dual RNAs enables highly efficient target digestion, leading to generation of knock-in
mice carrying a functional cassette with up to 50% efficiency, compared with just 10% by a commonly used
method consisting of Cas9 mRNA and single guide RNA. Our cloning-free CRISPR/Cas system facilitates rapid
one-step generation of cassette knock-in mice, accelerating functional genomic research by providing various
in vivo genetic tools.Background
Although gene-targeted knockout and knock-in mice are
invaluable tools for understanding the functions of genes
in vivo, the production of such genetically modified mice
has relied on gene targeting in embryonic stem cells,
which is a complicated and time-consuming process [1].
The recent development of the clustered regularly inter-
spaced short palindromic repeat (CRISPR)/CRISPR-associated
protein (Cas) system, a genome editing technology, has
allowed for the direct manipulation of the genome in
mouse zygotes in vivo (in vivo genome editing) with
extremely high efficiency, enabling the highly convenient
and ultra-rapid one-step generation of genetically modi-
fied mice without embryonic stem cells [2,3].
A flood of studies using CRISPR/Cas-mediated in vivo
genome editing have reported the production of knock-
out mice [4-6] and knock-in mice carrying single nucleo-
tide substitutions combined with oligo DNA donors
[5,7,8]. In contrast, there has been only one report on
the successful production of knock-in mice carrying re-
porter gene cassettes [9], essential tools for analyzing
complex tissues such as brain in vivo [10], and the effi-
cacy of the targeted insertion of the reporter gene was* Correspondence: tanaka.aud@mri.tmd.ac.jp
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unless otherwise stated.only about 10% [2,3,9,11]. The low success rates of gene
cassette knock-in limit the applicability of CRISPR/Cas-
mediated in vivo genome editing.
The CRISPR/Cas system was initially reported as an
adaptive immune system in bacteria, consisting of three
components including Cas9 nuclease and two small
RNAs, CRISPR RNA (crRNA), which guides the Cas9
complex to the target sequence, and trans-activating
crRNA (tracrRNA), which binds to crRNA and forms a
ribonucleoprotein complex with Cas9 nuclease [12].
When it was harnessed as a genome editing tool [13,14],
the dual-crRNA:tracrRNA was engineered as a chimeric
single guide RNA (sgRNA) [13]. The CRISPR/Cas sys-
tem consisting of two components - Cas9 nuclease and
sgRNA - is the most common approach in the field of
genome editing due to its enhanced convenience and ro-
bust targeting [15]. However, it is still unknown whether
the commonly used sgRNA works more efficiently than
the dual-crRNA:tracrRNA, especially for the production
of knock-in mice carrying reporter gene cassettes.
Here, we show the highly efficient generation of knock-
in mice carrying a functional gene cassette by a cloning-
free CRISPR/Cas system using Cas9 protein combined
with chemically synthesized dual-crRNA:tracrRNA.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Generation of highly active guide sequence
In a previous study, we demonstrated that the insertion
of a transgene downstream of the Actb polyadenylation
signal allowed for sufficiently high levels of gene induc-
tion [16,17]. Thus, we chose the Actb locus as a model
to be targeted for the generation of knock-in mice carry-
ing a functional gene cassette. We first designed the
guide sequence targeted to the locus 800 bp downstream
of the mouse Actb polyA signal (Figure 1a) and inserted
it into a bi-cistronic expression vector pX330 plasmid
[18,19] containing sequences encoding Cas9 and sgRNA
backbone sequences. Then, we determined its highFigure 1 Generation of knock-in mice carrying gene cassette by sgRNA com
of Actb-TetO-FLEX-EGFP-polyA knock-in mice. (b) Schematic diagram of pronu
vector. (c) PCR screening of knock-in newborns derived from pronuclear RNA
EGFP-polyA cassette. IF, internal forward primer; IR, internal reverse primer; KI,
primer; RR, right reverse primer; L-HA, left homology arm; R-HA, right homoloactivity of DNA digestion in vitro using a single-strand
annealing (SSA) assay with episomal plasmid vectors
containing a split luciferase gene and Actb target se-
quences in human HEK293T cell lines (Figure S1 in
Additional file 1), and a Cel-I assay in mouse Neuro2A
cell lines to target the endogenous mouse chromosome
(Figure S2 in Additional file 1).
To further test the activity of Actb sgRNA in vivo, we
injected Cas9 mRNA with Actb sgRNA - both in vitro
transcribed with T7 RNA polymerase using PCR tem-
plates amplified from an Actb pX330 plasmid [11] -
into one-cell stage mouse zygotes. We obtained 12
newborn mice and found that almost all the newbornsbined with Cas9 mRNA injection. (a) Targeting strategy for the generation
clear injection of Cas9 mRNA, Actb sgRNA and TetO-FLEX-EGFP targeting
injection. (d) Sequences of boundaries between Actb and TetO-FLEX-
knock-in; LF, left forward primer; LR, left reverse primer; RF, right forward
gy arm; M, molecular marker; WT, wild type.
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Table S1 in Additional file 1). Thus, the Actb sgRNA we
designed is highly active both in vitro and in vivo for
target digestion and subsequent induction of non-
homologous end-joining (NHEJ).
Generation of reporter knock-in mice by sgRNA combined
with Cas9 mRNA
As a model for knock-in mice carrying a functional gene
cassette, we designed reporter mice highly expressing
enhanced green fluorescent protein (EGFP) from the en-
dogenous Actb locus only in a specific cell population
intersectionally defined [20] by the expression of Cre re-
combinase and tetracycline transactivator (tTA). We
constructed a 10.5 kb targeting vector for the mouse
Actb locus containing a 2.5 kb TetO-FLEX-EGFP-polyA
cassette (Tet operator (tetO) sequence concatemers
fused to a minimal cytomegalovirus (CMV) promoter,
beta-globin intron, inverted EGFP flanked by two pairs
of loxP and lox2722 (FLEX switch) and polyA), and
2.0 kb left and right homology arms of the Actb locus
(Actb-TetO-FLEX-EGFP-polyA; Figure 1a).
Next, we injected the circular Actb-TetO-FLEX-EGFP-
polyA targeting vector together with Actb sgRNA and
Cas9 mRNA, both in vitro transcribed as above, into
one-cell-stage mouse zygotes (Figure 1b). We injected
the mixture (5 ng/μl Cas9 mRNA, 2.5 ng/μl Actb
sgRNA, and 10 ng/μl of the targeting vector) into pro-
nuclei as previously described [9]. We obtained eight
newborn mice and screened them by PCR with three dif-
ferent primer pairs (Figure 1a) and tail genomic DNA to
detect homologous recombination (HR). We found one
correctly targeted knock-in mouse carrying a TetO-
FLEX-EGFP-polyA cassette at the Actb locus (Figure 1c),
whereas the endogenous Actb loci were still targeted by
NHEJ in all the newborn mice (Table 1; and Figure S4 in
Additional file 1). The efficiency of the targeted insertion
of the transgene by pronuclear injection was 12.5%, con-
sistent with the previous report (Table 1) [9]. Next, we
sequenced cloned PCR products of the left and right
boundaries between Actb and the TetO-FLEX-EGFP-
polyA cassette and found the precise knock-in of the
cassette, as we designed (Figure 1d). These results con-
firm that the knock-in mouse carrying a functional gene
cassette can be generated by CRISPR/Cas-mediatedTable 1 Generation of reporter knock-in mice by Cas9 mRNA
Cas9 Guide RNA Injected Transferred
mRNA sgRNA 86 58 (67.4)
Protein sgRNA 135 112 (83.0)
Protein crRNA and tracrRNA 107 65 (60.7)
Percentages were calculated using the number in each column as the numerator and
Percentages of Knock-in were calculated using the number in the Knock-in column as
Note that the results of protein injections with high concentrations of guide RNAs arein vivo genome editing, although its efficiency is low
even when using highly active sgRNA for NHEJ.Generation of reporter knock-in mice by sgRNA combined
with Cas9 protein
To digest target genomic DNA, Cas9 mRNA injected
into pronuclei of mouse zygotes must be exported to the
cytoplasm, translated into protein, and imported into
the nucleus again. This long process [21] might delay
target digestion, leading to a low rate of HR. Consistent
with this idea, a recent in vitro cellular study reported
that the target genomic DNA was almost immediately
digested by the direct delivery of a Cas9 protein-sgRNA
complex compared with the delivery of plasmid DNA
expressing Cas9 and sgRNA [22]. Further, an in vivo
study in mice and zebrafish revealed that the direct de-
livery of a Cas9 protein-sgRNA complex into embryos
led to highly efficient generation of knockout animals
[23]. Thus, we hypothesized that direct delivery of a
Cas9 protein-RNA complex into the pronuclei of mouse
zygotes and subsequent rapid digestion of target gen-
omic DNA might improve the efficiency of knock-in
mouse generation.
First, we injected a mixture consisting of 30 or 100 ng/
μl Cas9 protein, 2.5 ng/μl Actb sgRNA, and 10 ng/μl tar-
geting vector into the pronuclei of zygotes (Figure 2a).
We obtained 39 newborn mice, although none carried
the TetO-FLEX-EGFP-polyA cassette at the Actb locus
(Figure S5 and Table S2 in Additional file 1). We also
found that the endogenous Actb locus was targeted by
NHEJ in only one mouse (Figure S6 and Table S2 in
Additional file 1). Next, we injected a mixture containing
a higher dose of sgRNA (30 or 100 ng/μl Cas9 protein,
25 ng/μl Actb sgRNA, and 10 ng/μl targeting vector) into
the pronulei of zygotes. We obtained 19 newborn mice,
but again none carried the TetO-FLEX-EGFP-polyA cas-
sette at the Actb locus (Figure 2b,c; Table S2 in Additional
file 1). We also found the endogenous Actb loci were tar-
geted by NHEJ in 5 out of the 19 mice (Figure S7 and
Table S2 in Additional file 1). Collectively, although we
generated 58 newborn mice by direct pronuclear delivery
of a Cas9 protein-sgRNA complex, we unexpectedly did
not obtain any knock-in mice carrying a functional gene
cassette (Table 1).or protein combined with sgRNA or crRNA/tracrRNA
(%) Newborn (%) Targeted (%) Knock-in (%)
8 (13.8) 8 (100) 1 (12.5)
19 (17.0) 5 (26.3) 0 (0)
11 (16.9) 9 (81.8) 5 (45.5)
the number in the column to its left as the denominator except for Knock-in.
the numerator and the number in the Newborn column as the denominator.
shown. All results are shown in Tables S2 and S3 in Additional file 1.
Figure 2 Generation of knock-in mice carrying a gene cassette by sgRNA combined with Cas9 protein injection. (a) Schematic diagram of pronuclear
injection of Cas9 protein, sgRNA, and TetO-FLEX-EGFP-polyA targeting vector. (b,c) PCR screening of knock-in newborns derived from 30 (b) or
100 ng/μl (c) Cas9 protein injection. Note that the size of the IF+IR PCR product in lane 3 in (c) is lower than that of the knock-in PCR product. IF,
internal forward primer; IR, internal reverse primer; KI, knock-in; LF, left forward primer; LR, left reverse primer; RF, right forward primer; RR, right reverse
primer; M, molecular marker; WT, wild type.
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To explore highly efficient knock-in systems based on
the Cas9 protein, we tested the initial form of the
CRISPR/Cas system consisting of three components in-
cluding Cas9, crRNA and tracrRNA (dual RNAs). The
short lengths of crRNA and tracrRNA are appropriate
for their chemical synthesis, enabling a cloning-free
CRISPR/Cas system when combined with Cas9 protein.
Taking advantage of the cloning-free CRISPR/Cas system,
we tried to simplify the evaluation process of CRISPR ac-
tivity generally performed in cultured cells. We developed
a cell-free in vitro digestion assay (IDA) system [13] using
the target Actb PCR product, Cas9 protein, and chemically
synthesized dual RNAs (Figure 3a). We chemically synthe-
sized Actb crRNA containing identical 20 nucleotide guide
sequences of Actb sgRNA and tracrRNA. We tested the
target digestion activities of various concentrations of
chemically synthesized dual RNAs combined with Cas9
protein by IDA. We found that chemically synthesized
dual RNAs efficiently digested target DNA in a dose-dependent manner with Cas9 protein (Figure 3b). We
then compared the target digestion activities of chemically
synthesized dual RNAs with in vitro transcribed Actb
sgRNA. We found that both the sgRNA and dual RNAs
combined with Cas9 protein digested the target Actb PCR
product with efficiencies of over 95% (Figure 3c). These
results suggest that the digestion activity of CRISPR/Cas
can be quickly and conveniently evaluated using IDA
without cultured cells [13], and chemically synthesized
RNAs can be used instead of in vitro transcribed sgRNA,
enabling a cloning-free CRISPR/Cas system.
Highly efficient generation of reporter knock-in mice by
dual-crRNA:tracrRNA combined with Cas9 protein
Next, we tested whether the knock-in efficiency was im-
proved by the cloning-free CRISPR/Cas system. We first
injected a mixture of 30 ng/μl Cas9 protein, 0.061 pmol/
μl Actb crRNA, 0.061 pmol/μl tracrRNA, and 10 ng/μl
targeting vector into the pronuclei of zygotes (Figure 4a).
The molar concentrations of dual RNAs were equivalent
Figure 3 Cloning-free CRISPR/Cas system. (a) Schematic diagram of the in vitro digestion assay with Cas9 protein. The PCR product is the Actb
PCR product amplified from wild-type mouse genomic DNA with internal forward and internal reverse primers. (b) The dose-dependency of
target digestion by chemically synthesized crRNA/tracrRNA with Cas9 protein (n = 3). RNA concentrations represent the concentration of each
crRNA and tracrRNA. (c) The efficiencies of target digestion by Cas9 protein only, Cas9 protein and sgRNA, and Cas9 protein and chemically
synthesized crRNA/tracrRNA (n = 4, respectively). Statistical significance was determined by one-way ANOVA and post hoc Tukey-Kramer test.
**P < 0.01. M, molecular marker.
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newborn mice, but none carried the TetO-FLEX-EGFP-
polyA cassette at the Actb locus (Figure S8 and Table S3
in Additional file 1), consistent with the low digest activity
at this concentration shown by IDA in vitro (Figure 3b),
and the endogenous Actb loci were targeted by NHEJ
in three out of eight mice (Figure S9 and Table S3 in
Additional file 1). Next, we injected a mixture containing
a higher dose of the dual RNAs (30 ng/μl Cas9 protein,
0.61 pmol/μl Actb crRNA, 0.61 pmol/μl tracrRNA, and
10 ng/μl targeting vector) into the pronulei of zygotes.
Surprisingly, we found 5 correctly targeted knock-in mice
among 11 newborn mice (Figure 4b). The efficiency of the
targeted insertion of the transgene by Cas9 protein injec-
tion combined with a higher dose of chemically synthe-
sized crRNA and tracrRNA was 45.5% (Table 1). We
further confirmed genotypes by Southern blotting with
genomic DNA of knock-in newborns (Figure 4c). We also
found the endogenous Actb loci were targeted by NHEJ in
four out of six non-knock-in mice (Table 1; Figure S10
and Table S3 in Additional file 1). These results suggest
that the direct pronuclear delivery of the Cas9 protein-
chemically synthesized dual RNAs complex majorly facili-
tates the generation of knock-in mice carrying a functional
gene cassette.
Because all the knock-in mice we generated were het-
erozygous for the TetO-FLEX-EGFP-polyA cassette at
the Actb loci (Figures 1c and 4b,c), we investigated dam-
age to non-knock-in alleles of these knock-in mice. We
cloned a 400 bp band of PCR product amplified withinternal forward and internal reverse primers, and se-
quenced them. Four out of six knock-in mice showed
damage to non-knock-in alleles, including small deletions
and long insertions (Figure S11 in Additional file 1). Inter-
estingly, we found that one knock-in mouse (Protein_KI-#3)
carried a 749 bp insertion corresponding to a part of
Trim33 'mRNA' which expands on three exons at chromo-
some 3 whereas Actb is located on chromosome 5. These
results suggest that non-knock-in alleles were damaged in
about half of the knock-in mice generated by Cas9 protein
combined with dual RNAs.
We further investigated off-target cleavage in the knock-
in mice, which is the most serious problem [24-27] associ-
ated with CRISPR/Cas-mediated genome editing. We
chose 14 off-target candidate loci (OT1-14) containing up
to 3 bp mismatches compared with the 20 bp guide
sequence of Actb crRNA [18,25]. Among 13 off-target
candidate loci (OT6 could not be amplified by PCR) in 6
knock-in mice, we did not find any sign of off-target diges-
tion (Figure S12 and Table S4 in Additional file 1). These
results suggest that in vivo genome editing by Cas9
protein combined with dual RNAs is highly specific for
the on-target locus.
Finally, we crossed F0 knock-in mice with wild-type
mice to investigate germline transmission of the knock-
in alleles to the F1 generation. We tested four knock-in
lines using PCR and Southern blotting and found that
all showed successful germline transmission in F1 pro-
geny with an average efficiency of 51.4% (ranging from
37.5% to 61.1% between lines) (Figures S13 and S14, and
Figure 4 Highly efficient generation of knock-in mice carrying a gene cassette by the cloning-free CRISPR/Cas system. (a) Schematic diagram of
pronuclear injection of Cas9 protein, chemically synthesized crRNA and tracrRNA and TetO-FLEX-EGFP-polyA targeting vector. (b) PCR screening of
knock-in newborns derived from pronuclear protein injection. (c) Southern blotting of knock-in newborns derived from pronuclear protein injection.
The knock-in mice, Protein_KI-#1, 3, 4, and 5, correspond to the newborn mice 1, 5, 8, and 11 in (b), respectively. IF, internal forward primer; IR, internal
reverse primer; KI, knock-in; LF, left forward primer; LR, left reverse primer; RF, right forward primer; RR, right reverse primer; M, molecular marker; WT,
wild type.
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the percentage of mosaicism in F0 knock-in mice was
very low.
Functionality of the reporter cassette inserted at the Actb
locus
Finally, we tested whether the TetO-FLEX-EGFP-polyA
cassette inserted into the mouse Actb locus is effective.
We transfected Cre-, tTA-, and DsRed-expressing plas-
mids into primary mouse fibroblasts derived from ear tips
of three F0 knock-in and control littermates (Figure 5a).
We found strong EGFP fluorescence only in fibroblasts
derived from knock-in mice (Figure 5b). These results
suggest that functional EGFP proteins are produced fromthe TetO-FLEX-EGFP-polyA cassette inserted into the en-
dogenous Actb locus under the presence of Cre and tTA.
Discussion
In this study, we developed a cloning-free CRISPR/Cas-
mediated genome editing system for highly efficient and
convenient one-step generation of knock-in mice carry-
ing a functional gene cassette. This system has several
advantages. First, the CRISPR/Cas vector construction
and in vitro RNA transcription can be omitted by using
commercially available Cas9 protein and chemically syn-
thesized crRNA and tracrRNA, leading to a cloning-free
CRISPR/Cas system. Although chemical synthesis of
sgRNA might also be possible and convenient, technical
Figure 5 Functionality of the reporter cassette inserted at the Actb locus. (a) Schematic diagram of primary fibroblast cultures and transfection of
three plasmids. (b) Confocal images of transfected fibroblasts derived from knock-in (KI) mice and their control littermates (wild type, WT).
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100 mer) must be considered. In contrast, shorter
crRNAs and tracrRNAs can be chemically synthesized
easily in a cost-effective manner. Furthermore, tracrR-
NAs can be commonly used independently of target se-
quences as well as Cas9 protein. The targeting vectors
are already chemically synthesizable. Second, the effi-
ciency of CRISPR/Cas-mediated digestion can be evalu-
ated with a cell-free IDA system using target Actb PCR
product, Cas9 protein, and chemically synthesized
crRNA and tracrRNA, instead of cellular SSA or Cel-I
assays. Third, and most importantly, the direct delivery
of Cas9 protein, chemically synthesized crRNA and
tracrRNA, and targeting vector into the pronuclei of zy-
gotes allowed for the highly efficient generation of
knock-in mice carrying gene cassettes in the endogenous
gene. Since we could not obtain any knock-in mice by
the direct delivery of Cas9 protein, sgRNA, and targeting
vector into the pronuclei of zygotes, the high knock-in
efficiency of the cloning-free CRISPR/Cas system was me-
diated by use of crRNA and tracrRNA, not conventional
sgRNA. Although both sgRNA and dual RNAs combined
with Cas9 protein efficiently digested the target Actb PCR
product in a biochemical IDA (Figure 3c), the enzymatic
reaction conditions were completely different from those
of zygote injection, leading to discrepancy in NHEJ and
HR efficiencies in vivo. Consistent with this idea, although
the sgRNA co-injected with Cas9 mRNA showed high
NHEJ efficiency regardless of targeting vector (Table 1;
Table S1 in Additional file 1), the sgRNA combined with
Cas9 protein showed much less NHEJ efficiency (Table 1;
Table S2 in Additional file 1), suggesting non-optimal as-
sembly of Cas9 protein and sgRNA to form a highly active
ribonucleoprotein complex. Taken together, the cloning-
free CRISPR/Cas system facilitates functional cassette
knock-in into the mouse chromosome.
In contrast to the highly efficient (almost 100%) gener-
ation of NHEJ-mediated knockout mice by the injection
of Actb sgRNA and Cas9 mRNA, we demonstratedmuch lower efficiency of HR-mediated generation of
knock-in mice by the injection of these RNAs combined
with targeting vector. One possible explanation for this
is the difference in the injection method. For knockout
mice production, we injected Actb sgRNA and Cas9
mRNA into the cytoplasm, which presumably led to fast
translation of Cas9 mRNA into protein, as described
previously [5,6]. For knock-in mice production, because
pronuclear injection [5,7-9] is a standard method for de-
livering RNA and targeting vector into one-cell-stage
mouse zygotes, we injected the mixture of Actb sgRNA,
Cas9 mRNA and targeting plasmid vector into the pro-
nuclei, which might lead to delays in the translation of
Cas9 mRNA into protein.
Rapid digestion of target genomic DNA within one-
cell zygotes may also be critical for highly efficient in-
duction of HR. In a previous cellular study, it was shown
that the target genomic DNA was almost immediately
digested by the direct delivery of the Cas9 protein-RNA
complex [22]. Further, highly efficient generation of
knockout mice by the direct delivery of the Cas9
protein-RNA complex was reported [23]. Thus, direct
injection of the Cas9 protein-RNA complex into pro-
nuclei may result in immediate digestion of the target
endogenous locus of mouse zygotes at the early one-cell
stage, leading to highly efficient knock-in of the func-
tional cassette. Consistent with this view, knock-in al-
leles in four knock-in mice generated by injection of a
Cas9 protein-dual RNAs complex were successfully
transmitted to F1 progeny with about 50% efficiency.
It was also reported that a Cas9 protein-RNA complex
was rapidly degraded in cultured cells, thus reducing un-
desired off-target effects [22,28], the most serious problem
[24-27] associated with CRISPR/Cas-mediated genome
editing. In contrast to high off-target effects in cultured
cell lines [24-27], its frequency is thought to be relatively
rare in embryonic stem cells and mouse embryos [9]. Our
off-target analysis in several candidate loci in knock-in
mice confirmed the high accuracy of the CRISPR/Cas
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mouse embryos. Although non-biased genome-wide off-
target analysis [29-31] or whole-genome sequencing
[32-34] will be required, use of the Cas9 protein-dual
RNAs complex is a promising approach for highly specific
genome editing. Thus, our cloning-free CRISPR/Cas-me-
diated in vivo genome editing system provides highly effi-
cient and highly accurate generation of knock-in mice
carrying functional cassettes.
The insertion of several hundred nucleotides is often
found at the targeted loci when using genome editing,
although the origin of the inserted sequence is unknown
[35]. One possible source of the insertion is the tran-
scribed RNA. Recent studies suggest that DNA double-
strand breaks (DSBs) are repaired by using the DNA that
is reverse-transcribed from mRNA in mammalian cells
[36], yeast [37], and fly [38]. We found trans-insertion of
Trim33 mRNA into the Actb locus in our knock-in
mouse, providing direct evidence of transcript RNA-
templated DNA DSB repair in mammalian organisms
in vivo. Transcript RNA-templated repair of DNA DSBs
is mutagenic and polymorphic in the human genome
[36], suggesting that it may play an important role in
human genetic diseases and evolution. Thus, our results
shed light on transcript RNA-templated DNA DSB
repair in mammalian organisms in vivo and stimulate
functional research on this.
In addition to the generation of knock-in mice carry-
ing complex gene cassettes, our method can be directly
applied to the generation of knockout mice [23] and
knock-in mice carrying single nucleotide substitutions
with oligo DNA donors [5,7,8], as well as to other spe-
cies [39-41] and cultured cells [22,28], and in vivo gen-
ome editing in adult animals [42]. Taken together, our
streamlined cloning-free CRISPR/Cas-mediated in vivo
genome editing system enables the highly efficient and
extremely convenient one-step generation of knock-in
mice carrying functional gene cassettes.
Conclusions
Cas9 protein and chemically synthesized crRNA and
tracrRNA enabled cloning-free CRISPR/Cas system with-
out CRISPR vector construction, cellular experiments for
evaluation of the digestion activity of CRISPR/Cas, and
in vitro RNA transcription. By the direct nuclear delivery
of Cas9 protein complex combined with dual RNAs into
one-cell mouse zygotes, knock-in mice carrying functional
cassette were generated with extreme high efficiency,
which could not be achieved by conventional mRNA pro-
nuclear injection or Cas9 protein injection combined with
commonly used sgRNA. Taken together, our streamlined
cloning-free CRISPR/Cas-mediated in vivo genome edit-
ing system provides the highly efficient and extremely
convenient one-step generation of knockout and knock-inanimals, leading to acceleration of in vivo functional gen-
omic research.Materials and methods
Animal experiments
All research and animal care procedures were approved
by the Tokyo Medical and Dental University Animal
Care and Use Committee. Mice were housed in groups
of three to five animals per cage and maintained on a
regular 12 hours light/dark cycle (8:00 to 20:00 light
period) at a constant 25°C. Food and water were avail-
able ad libitum.CRISPR/Cas plasmid
A pair of oligo DNAs (Hokkaido Systems Science, Sapporo,
Hokkaido, Japan) corresponding to Actb sgRNA was hy-
bridized and ligated using Quick Ligase (New England
BioLabs (NEB), Ipswich, MA, USA) into linearized
pX330 plasmid (Addgene, 42230; Feng Zhang, MIT)
digested with BbsI (NEB) as previously described [18,19].
Oligo DNAs and primers are listed in Table S6 in
Additional file 1.Targeting vector
The pActb-TetO-FLEX-EGFP-polyA targeting vector
was constructed based on a pAAV-TetO-FLEX-HA-
mKate2-TeNT-polyA plasmid (a gift from Akihiro
Yamanaka, Nagoya University) with several modifica-
tions. First, HA-mKate2-TeNT was excised by digestion
with XhoI (NEB) and HindIII (NEB), and replaced with
PCR amplified inverted EGFP. Second, AAV2-ITR was
excised by digestion with NarI (NEB) and BstEII (NEB),
and replaced with a PCR-amplified 2.0 kb Actb fragment
from C57BL/6 J mouse genomic DNA for left homology
arm using a In-Fusion HD Cloning Kit (Takara, Otsu,
Shiga, Japan). Finally, the PCR-amplified 2.0 kb Actb
fragment for right homology arm was inserted into the
plasmid digested with NotI (NEB) and MluI (NEB) by
In-Fusion reaction.Single-strand annealing assay
SSA assay using HEK293T cells was performed as de-
scribed previously [43]. Briefly, Actb-pX330 or empty
pX330 plasmids, firefly luciferase reporter vector contain-
ing the PCR-amplified Actb target sequence (Table S6 in
Additional file 1), and renilla luciferase-expressing refer-
ence vector were co-transfected into HEK293T cells in a
96-well plate using Lipofectamine LTX (Life Technologies,
Grand Island, NY, USA). At 24 hours post-transfection,
luciferase activity was measured using the Dual-Glo
Luciferase Assay System (Promega, Madison, WI, USA)
according to the manufacturer’s instructions.
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Cel-I assay using Mouse Neuro2A cells was performed
as described previously [43]. Briefly, Actb-pX330 or
empty pX330 plasmids was transfected into Neuro2A
cells in a 6-well plate using Lipofectamine LTX (Life
Technologies). After 72 hours post-transfection, gen-
omic DNA was isolated using a DNeasy Blood & Tissue
Kit (Qiagen, Valencia, CA, USA). Then, Actb loci were
PCR amplified from the purified genomic DNA with
primers (Table S6 in Additional file 1). PCR products
were denatured, digested at 42°C for 30 minutes with a
Surveyor Mutation Detection Kit (Transgenomic, Omaha,
NE, USA), and analyzed by electrophoresis in 3% agarose
gel stained with ethidium bromide. Gel images were ob-
tained with a ChemiDoc XRS system (Bio-Rad, Hercules,
CA, USA) and analyzed by Image Lab software (Bio-Rad).
In vitro RNA transcription
Cas9 mRNA and Actb-sgRNA were prepared as described
previously [5]. Cas9 and Actb-sgRNA were PCR amplified
from Actb-pX330 with T7 promoter-attached primers
(Table S6 in Additional file 1). T7-Cas9 and T7-Actb-
sgRNA PCR products were purified with a PCR Purifica-
tion Kit (Qiagen) and used as the template for in vitro
transcription using a mMESSAGE mMACHINE T7
ULTRA Kit (Life Technologies) and MEGAshortscript T7
Kit (Life Technologies). Cas9 mRNA and Actb-sgRNA
were purified with a MEGAclear Kit (Life Technologies)
and eluted with Nuclease-free water (Life Technologies).
The quality of RNAs was analyzed using a NanoDrop
(Thermo Scientific, Waltham, MA, USA) and Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA).
Cas9 proteins
The recombinant Cas9 proteins were obtained from
NEB and PNA Bio (Thousand Oaks, CA, USA).
Chemical synthesis of crRNA and tracrRNA
Actb-crRNA (5′-cauuaugaguccuuaagugaGUUUUAGAGC
UAUGCUGUUUUG-3′) and -tracrRNA (5′- AAACAG
CAUAGCAAGUUAAAAUAAGGCUAGUCCGUUAUCA
ACUUGAAAAAGUGGCACCGAGUCGGUGCU-3′)
were designed with some modification of previously re-
ported methods [12,19], and chemically synthesized and
purified by polyacrylamide gel electrophoresis (Fasmac,
Atsugi, Kanagawa, Japan).
In vitro digestion assay
Cas9 proteins (30 ng/μl) and chemically synthesized Actb-
crRNA (8.7 ng/μl) and -tracrRNA (14.3 ng/μl), or in vitro
transcribed Actb-sgRNA (25 ng/μl) were incubated with
Actb target PCR products (30 ng/μl) in a Cas9 Nuclease
Reaction Buffer (NEB) at 37°C for 60 minutes as previ-
ously described [13], then treated with RNase A (5 mg)and incubated at 37°C for 30 minutes to remove RNA
[44]. Reactions were stopped with 6× DNA loading buffer
containing 30% glycerol, 1.2% SDS and 250 mM EDTA,
and analyzed by electrophoresis in 2% agarose gel as de-
scribed above.
Injection
For knockout mouse production, Cas9 mRNAs and
Actb-sgRNA were diluted and mixed in 0.1 TE buffer
(10 mM Tris-HCl, 0.1 mM EDTA (pH 8.0)) to a working
concentration of 50 and 20 ng/μl, respectively. One-cell-
stage zygotes were obtained by mating of BDF1 males
and females (CLEA Japan, Meguro, Tokyo, Japan), and
then frozen and stored until use. The mixture of Cas9
mRNAs and Actb-sgRNA was injected into the cyto-
plasm using a micromanipulator and microscope (Leica,
Wetzlar, Germany) and injector (Eppendorf, Hauppauge,
NY, USA). After incubation at 37°C for 24 hours, two-
cell-stage embryos were transferred into pseudopregnant
ICR female mice (CLEA Japan).
For knock-in mouse production by RNA injection, Cas9
mRNAs, Actb-sgRNA, and pActb-TetO-FLEX-EGFP-polyA
were diluted and mixed in 0.1 TE buffer to a working con-
centration of 5, 2.5, and 10 ng/μl, respectively, as previously
described [5]. The injection mixture was injected into pro-
nuclei of one-cell-stage zygotes.
For knock-in mouse production by protein injection, Cas9
proteins, Actb-sgRNA, or Actb-crRNA and tracrRNA, and
pActb-TetO-FLEX-EGFP-polyA were diluted and mixed in
0.1 TE buffer to a working concentration of 30 or 100 ng/μl,
2.5 or 25 ng/μl, or 0.061 or 0.61 pmol/μl, and 10 ng/μl,
respectively. The mixture was incubated at 37°C for at least
15 minutes, and then injected into pronuclei of one-cell-
stage zygotes.
PCR screening
Genomic DNA was prepared from F0 and F1 newborn
tails by proteinase K treatment and a subsequent stand-
ard phenol extraction method as described previously
[45,46]. Knock-in mice were screened by PCR with
ExTaq (Takara) and three different pairs of primers
(Table S6 in Additional file 1) and analyzed by electro-
phoresis in 1 or 2% agarose gel as described above. PCR
products were further cloned with TOPO TA Cloning
Kit (Life Technologies) and analyzed by sequencing.
Southern blotting
Southern probe (0.7 kb) was PCR amplified (Primers:
Table S6 in Additional file 1) from BDF1 genomic DNA
and cloned with a TOPO TA Cloning Kit, and DIG-
labeled with a DIG-High Prime DNA Labeling and De-
tection Starter Kit II (Roche, Penzberg, Upper Bavaria,
Germany). The genomic DNA was digested with HindIII
and separated on 0.7% agarose gel, transferred to nylon
Aida et al. Genome Biology  (2015) 16:87 Page 10 of 11membranes, positively charged (Roche), hybridized with
DIG-labeled probe, and detected with CDP-Star (Roche)
as previously described [47].Off-target effects
The potential off-target candidate loci containing up to
3 bp mismatches compared with the 20 bp guide se-
quence of Actb sgRNA were predicted by the CRISPR
design tool [18,25,48]. The off-target candidate loci were
amplified by PCR using primers listed in Table S6 in
Additional file 1 and analyzed by direct sequencing as
previously described [47].Primary fibroblast cultures
The ear tips derived from 2-week-old mice were diced
into small pieces, incubated at 37°C for 30 minutes with
4 mg/ml collagenase L (Nitta Gelatin, Naniwa, Osaka,
Japan) and 4 mg/ml dispase (Life Technologies), and
then cultured with 10% fetal bovine serum/Dulbecco’s
modified eagle medium at 37°C and 10% CO2 for several
days. pCAG-Cre, pCMV-tTA (Takara), and pCMV-
DsRed (Takara) were co-transfected into primary fibro-
blast cells in a six-well plate using Lipofectamine LTX
with Plus reagent (Life Technologies). Images were ac-
quired on a FV500 confocal microscope and Fluoview
software (Olympus, Shinjuku, Tokyo, Japan).Statistical analyses
All data are presented as the mean ± standard error of
the mean. Statistical methods were described in the fig-
ure legends for each data set. Briefly, Student’s t-tests
were used to compare differences between any two
groups. One-way ANOVA with post hoc Tukey-Kramer
tests were used to compare differences between three
groups. Statistical significance was set at P < 0.05.Additional file
The following additional data are available with the on-
line version of this paper.
Additional file 1: Cellular assays, generation of knockout and
knock-in mice, sequencing of all the newborns and non-knock-in al-
leles, germline transmission, off-target analysis, and tables of these
results and a list of the oligo DNAs and primers used in this study.Abbreviations
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